Evidence map›Paper›PMID 40355627›Full record

ArticleNeuro-oncology2025

Decoding the cancer cell proteome: A delicate equilibrium with the genome and epigenome.

Ryan J Duchatel, Javad Nazarian

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ryan J DuchatelPrecision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Javad NazarianSchool of Medicine and Health Sciences, The George Washington University, Washington, District of Columbia, USA.ORCID 0000-0002-1951-9828

Funding

Phase 0/1 trial of ONC206 - a novel imipridone for children with diffuse midline gliomas and recurrent malignant brain tumorsR01CA266596 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sabine Mueller · 2022 to 2026
$2.4M
Borne Hjernecancer FondenIsabella Kerr Foundation, Swiss to Cure DIPG Foundation, ChadTough Defeat DIPG fellowship, Rising Tide Foundation CCR-20-500NCI NIH HHS R01 CA266596NIH HHS CA266596Swiss National Science Foundation - Sinergia CRSII5_198739
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40355627
PMCPMC12417827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.